thioridazine has been researched along with Latent Tuberculosis in 3 studies
Thioridazine: A phenothiazine antipsychotic used in the management of PHYCOSES, including SCHIZOPHRENIA.
thioridazine : A phenothiazine derivative having a methylsulfanyl subsitituent at the 2-position and a (1-methylpiperidin-2-yl)ethyl] group at the N-10 position.
Latent Tuberculosis: The dormant form of TUBERCULOSIS where the person shows no obvious symptoms and no sign of the causative agent (Mycobacterium tuberculosis) in the SPUTUM despite being positive for tuberculosis infection skin test.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Models have been developed to study latent tuberculosis with the two most prominent being the in vivo murine model and the in vitro Wayne model." | 6.47 | Latent tuberculosis: is there a role for thioridazine? ( Sohaskey, C, 2011) |
| "Further, a murine model of latent tuberculosis was used and the standard 9-month isoniazid and 4-month rifampicin regimen along with thioridazine as an adjunct drug were evaluated." | 5.40 | Chemotherapeutic efficacy of thioridazine as an adjunct drug in a murine model of latent tuberculosis. ( Sharma, S; Singh, A, 2014) |
| "Further, a murine model of latent tuberculosis was used and the standard 9-month isoniazid and 4-month rifampicin regimen along with thioridazine as an adjunct drug were evaluated." | 1.40 | Chemotherapeutic efficacy of thioridazine as an adjunct drug in a murine model of latent tuberculosis. ( Sharma, S; Singh, A, 2014) |
| "This thioridazine exposure was calculated to extinguish all three M." | 1.39 | Thioridazine pharmacokinetic-pharmacodynamic parameters "Wobble" during treatment of tuberculosis: a theoretical basis for shorter-duration curative monotherapy with congeners. ( Gumbo, T; Leff, R; Meek, C; Musuka, S; Pasipanodya, J; Siyambalapitiyage Dona, CW; Srivastava, S, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Musuka, S | 1 |
| Srivastava, S | 1 |
| Siyambalapitiyage Dona, CW | 1 |
| Meek, C | 1 |
| Leff, R | 1 |
| Pasipanodya, J | 1 |
| Gumbo, T | 1 |
| Singh, A | 1 |
| Sharma, S | 1 |
| Sohaskey, C | 1 |
1 review available for thioridazine and Latent Tuberculosis
| Article | Year |
|---|---|
Latent tuberculosis: is there a role for thioridazine?
Topics: Animals; Antitubercular Agents; Drug Discovery; Drug Resistance, Multiple, Bacterial; Drug Therapy, | 2011 |
2 other studies available for thioridazine and Latent Tuberculosis
| Article | Year |
|---|---|
Thioridazine pharmacokinetic-pharmacodynamic parameters "Wobble" during treatment of tuberculosis: a theoretical basis for shorter-duration curative monotherapy with congeners.
Topics: Antipsychotic Agents; Antitubercular Agents; Colony Count, Microbial; Computer Simulation; Drug Admi | 2013 |
Chemotherapeutic efficacy of thioridazine as an adjunct drug in a murine model of latent tuberculosis.
Topics: Animals; Antitubercular Agents; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relat | 2014 |